- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
The Top A.I. Stories of 2022
AI continued to grow over the last year, and more life sciences companies are embracing the new technology in a variety of ways.
Digital Biomarkers Could Reshape CNS Diagnosis, Treatment
AI drives new signal-detection efforts in Alzheimer’s and ALS.
AI + Social Media: The Intersection of 2 Contemporary Inventions Takes Physician Engagement to the Next Level
The two technologies are helping HCPs spread information and collect data in new ways.
Q&A with Jason Smith, CTO at Within3
Jason Smith discusses his work with AI-based data platforms.
Smarter Signal Management: AI, Big Data, and Predictive Analytics
What if you could predict potential safety issues before clinical development begins? Innovative new signal detection and management approaches have been developed to help clinical trial sponsors, manufacturers, and CROs combat safety-related challenges and provide insight to be used to predict potential safety issues even before clinical development begins. Applying those learnings to their choice of initial research candidates can ultimately mean safer medicines for patients.
Why Machine Learning's Potential in Pharma Relies on Its Transparency
Despite the rapid innovation of machine learning, correct protocols to ensure compliance and trustworthiness must be considered.
The Impact of Artificial Intelligence on the Creation of Medicines
October 24th 2024Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.
Plan Ahead: Mastering Your AI Budget for 2025 Success
October 9th 2024Generative AI is just one part of the artificial intelligence and machine learning that is being used by life science organizations, emerging as a major area of interest and an area in which costs and ROI are still largely unknown.
